1.Combined Endoscopic Third Ventriculostomy and Lumboperitoneal Shunt Surgery in an Elderly Patient With Complex Hydrocephalus: Mixture of Late-onset Obstructive and Communicating Hydrocephaluses
Sang-Youl YOON ; Kyunghun KANG ; Chaejin LEE ; Jeong-Hyun HWANG ; Myoung Hun HAHM ; Eunhee PARK ; Ki-Su PARK
Dementia and Neurocognitive Disorders 2023;22(1):46-48
2.Genetic Variants and Clinical Phenotypes in Korean Patients With Hereditary Hemorrhagic Telangiectasia
Bo-Gyeong KIM ; Joo-hyun JUNG ; Mi-Jung KIM ; Eun-Hye MOON ; Jae-Hwan OH ; Jung-Woo PARK ; Heung-Eog CHA ; Ju-Hyun KIM ; Yoon-Jae KIM ; Jun-Won CHUNG ; Ki-Baik HAHM ; Hong-Ryul JIN ; Yong-Ju JANG ; Sung Wan KIM ; Seung-Kyu CHUNG ; Dae-Woo KIM ; Young Jae LEE ; Seon-Tae KIM
Clinical and Experimental Otorhinolaryngology 2021;14(4):399-406
Objectives:
. Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder characterized by recurrent epistaxis, telangiectasia, and visceral arteriovenous malformations (AVMs). Activin A receptor-like type 1 (ACVRL1/ALK1) and endoglin (ENG) are the principal genes whose mutations cause HHT. No multicenter study has yet investigated correlations between genetic variations and clinical outcomes in Korean HHT patients.
Methods:
. Seventy-two members from 40 families suspected to have HHT based on symptoms were genetically screened for pathogenic variants of ACVRL1 and ENG. Patients with genetically diagnosed HHT were also evaluated.
Results:
. In the HHT genetic screening, 42 patients from 24 of the 40 families had genetic variants that met the pathogenic criteria (pathogenic very strong, pathogenic strong, pathogenic moderate, or pathogenic supporting) based on the American College of Medical Genetics and Genomics Standards and Guidelines for either ENG or ACVRL1: 26 from 12 families (50%) for ENG, and 16 from 12 families (50%) for ACVRL1. Diagnostic screening of 42 genetically positive HHT patients based on the Curaçao criteria revealed that 24 patients (57%) were classified as having definite HHT, 17 (41%) as having probable HHT, and 1 (2%) as unlikely to have HHT. Epistaxis was the most common clinical presentation (38/42, 90%), followed by visceral AVMs (24/42, 57%) and telangiectasia (21/42, 50%). Five patients (12%) did not have a family history of HHT clinical symptoms.
Conclusion
. Only approximately half of patients with ACVRL1 or ENG genetic variants could be clinically diagnosed as having definite HHT, suggesting that genetic screening is important to confirm the diagnosis.
3.Effects of Genetic and Pharmacologic Inhibition of COX-2 on Colitis-associated Carcinogenesis in Mice
Jeong-Sang LEE ; Hyun Soo KIM ; Ki Baik HAHM ; Young-Joon SURH
Journal of Cancer Prevention 2020;25(1):27-37
COX-2 has been inappropriately overexpressed in various human malignancies, and is considered as one of the representative targetsfor the chemoprevention of inflammation-associated cancer. In order to assess the role of COX-2 in colitis-induced carcinogenesis,the selective COX-2 inhibitor celecoxib and COX-2 null mice were exploited in an azoxymethane (AOM)-initiated and dextransulfate sodium (DSS)-promoted murine colon carcinogenesis model. The administration of 2% DSS in drinking water for 1 week aftera single intraperitoneal injection of AOM produced colorectal adenomas in 83% of mice, whereas only 27% of mice given AOM alonedeveloped tumors. Oral administration of celecoxib significantly lowered the incidence as well as the multiplicity of colon tumors. Theexpression of COX-2 and inducible nitric oxide synthase (iNOS) was upregulated in the colon tissues of mice treated with AOM andDSS, and this was inhibited by celecoxib administration. Likewise, celecoxib treatment abrogated the DNA binding of NF-κB, a keytranscription factor responsible for regulating expression of aforementioned pro-inflammatory enzymes, which was associated withsuppression of IκBα degradation. In the COX-2 null (COX-2–/–) mice, there was about 30% reduction in the incidence of colon tumors,and the tumor multiplicity was also markedly reduced (7.7 ± 2.5 vs. 2.43 ± 1.4, P< 0.01). As both pharmacologic inhibition andgenetic ablation of COX-2 gene could not completely suppress colon tumor formation following treatment with AOM and DSS, it isspeculated that other pro-inflammatory mediators, including COX-1 and iNOS, should be additionally targeted to prevent inflammation-associated colon carcinogenesis.
4.Dynamic postural stability in patients with diabetic peripheral neuropathy and relationship to presence of autonomic neuropathy
Jong Ha Baek ; Hosu Kim ; Kyong Young Kim ; Min-Kyun Oh ; Ki-Jong Park ; Yoon Young Cho ; oo Kyoung Kim ; Jung Hwa Jung ; Hyun-Jung Kim ; Jaehoon Jung ; Hee Suk Shin ; Dawon Kang ; Ryeal Hahm
Neurology Asia 2018;23(4):303-311
Diabetic neuropathy is a common complication that can negatively influence balance and is a major
cause of falls. We evaluated the association between postural sway and diabetic autonomic neuropathy
(DAN) among patients with diabetic peripheral neuropathy (DPN). Patients with DPN documented by
typical symptoms with abnormal results of nerve conduction study were included and postural stability
was assessed using dynamic posturography. Composite autonomic scoring scale (CASS) score was
calculated by evaluating sudomotor, cardiovagal, and adrenergic functions. CASS score ≥2 indicated
DAN and the severity of DAN was indicated by the CASS scores divided into three subscales of
10-point total CASS: none or mild autonomic failure (0-3), moderate failure (4-6), and severe failure
(7-10). A total of 34 patients comprised the DAN group (n=19) and non-DAN group (n=15). Patients
with DAN had higher prevalence of diabetic retinopathy(p=0.011), higher urine albumin-creatinine
ratio (p = 0.009), and lower HbA1c levels (p<0.001) than those with non-DAN. With regard to dynamic
postural instability, the presence (p=0.025) as well as the severity of DAN (p<0.05) was associated
with postural instability in the eyes-opencondition. Interestingly, the poorer dynamic postural instability
in moderate/severe DAN compared to mild DAN was observed only in medio-lateral direction and
this association remained significant after adjusting for age, sex, and glycemic control state (HbA1c).
In patients with DAN accompanied by DPN, the dynamic postural instability was affected by visual
feedback and medio-lateral directional instability was closely associated with the severity of DAN.
5.Heme Oxygenase-1 Induction and Anti-inflammatory Actions of Atractylodes macrocephala and Taraxacum herba Extracts Prevented Colitis and Was More Effective than Sulfasalazine in Preventing Relapse.
Kyu Hyun HAN ; Jong Min PARK ; Migyeong JEONG ; Young Min HAN ; Eun Jin GO ; Juyeon PARK ; Hocheol KIM ; Jae Gab HAN ; Oran KWON ; Ki Baik HAHM
Gut and Liver 2017;11(5):655-666
BACKGROUND/AIMS: In inflammatory bowel disease (IBD), repeated bouts of remission and relapse occur in patients and can impose a risk of colitis-associated cancer. We hypothesized that plant extracts of Atractylodes macrocephala (AM) or Taraxacum herba (TH) may be better than sulfasalazine for treating this disease because these extracts can promote additional regeneration. METHODS: Murine intestinal epithelial IEC-6 cells were pretreated with AM or TH before a lipopolysaccharide (LPS)-induced challenge. Acute colitis was induced with 7 days of dextran sulfate sodium (DSS) in male C57BL/6 mice, and extracts of AM and TH were administered for 2 weeks before DSS administration. RESULTS: In vitro studies demonstrated that AM or TH treatment reduced LPS-induced COX-2 and tumor necrosis factor-α mRNA levels but increased heme oxygenase-1 (HO-1). Oral preadministration of AM and TH rescued mice from DSS-induced colitis by inhibiting inflammatory mediators via inactivated extracellular signal regulated kinase and repressed nuclear factor κB and signal transducer and activator of transcription 3, but the effect was weaker for sulfasalazine than that for the extracts. Anti-inflammatory activities occurred via the inhibition of macrophage and T lymphocyte infiltrations. Unlike sulfasalazine, which did not induce HO-1, TH extracts afforded significant HO-1 induction. CONCLUSIONS: Because the AM or TH extracts were far superior in preventing DSS-induced colitis than sulfasalazine, AM or TH extracts can be considered natural agents that can prevent IBD relapse.
Animals
;
Atractylodes*
;
Colitis*
;
Dextran Sulfate
;
Heme Oxygenase-1*
;
Heme*
;
Humans
;
In Vitro Techniques
;
Inflammation
;
Inflammatory Bowel Diseases
;
Lymphocytes
;
Macrophages
;
Male
;
Mice
;
Necrosis
;
Phosphotransferases
;
Plant Extracts
;
Recurrence*
;
Regeneration
;
RNA, Messenger
;
STAT3 Transcription Factor
;
Sulfasalazine*
;
Taraxacum*
6.Changes in small intestinal motility and related hormones by acupuncture stimulation at Zusanli (ST 36) in mice.
Jung-Hee JANG ; Deuk-Joo LEE ; Chang-Hwan BAE ; Ki-Tae HA ; Sunoh KWON ; Hi-Joon PARK ; Dae-Hyun HAHM ; Hyejung LEE ; Seungtae KIM
Chinese journal of integrative medicine 2017;23(3):215-220
OBJECTIVESTo clarify the effects of acupuncture stimulation at Zusanli (ST 36) on the hormonal changes.
METHODSEight-week-old male C57BL/6 mice received acupuncture stimulation at acupoint ST 36 or Quchi (LI 11) once a day for 3 or 5 days in the acupuncture-stimulated groups, but not received in the normal group (n=6 in each group). On day 3 or 5, animals were given 0.1 mL of charcoal orally with a bulbed steel needle, 30 min after the last acupuncture stimulation. Ten minutes later, mice were anesthetized, and the intestinal transit and the concentrations of vasoactive intestinal peptide (VIP), motilin, ghrelin and gastrin in the serum were measured.
RESULTSCompared to no acupuncture stimulation, acupuncture stimulation at ST 36 for 5 days increased the intestinal transit and down-regulated the concentration of VIP and up-regulated the concentrations of motilin, ghrelin and gastrin (P<0.05 or 0.01), whereas acupuncture stimulation at LI 11 did not change them signifificantly (P>0.05).
CONCLUSIONAcupuncture stimulation at ST 36 for 5 days enhances the small intestinal motility and regulates the secretion of hormones related to small intestinal motility.
Acupuncture Points ; Acupuncture Therapy ; Animals ; Gastrointestinal Motility ; physiology ; Hormones ; blood ; Intestine, Small ; physiology ; Male ; Mice, Inbred C57BL
7.Bile Flow Phantom Model and Animal Bile Duct Dilation Model for Evaluating Biliary Plastic Stents with Advanced Hydrophilic Coating.
Chang Il KWON ; Gwangil KIM ; Seok JEONG ; Won Seop LEE ; Don Haeng LEE ; Kwang Hyun KO ; Sung Pyo HONG ; Ki Baik HAHM
Gut and Liver 2016;10(4):632-641
BACKGROUND/AIMS: The efforts to improve biliary plastic stents (PSs) for decreasing biofilm formation and overcome short patency time have been continued. The aim of this study is to evaluate the effect of advanced hydrophilic coating for patency and biodurability of PS. METHODS: Using an in vitro bile flow phantom model, we compared patency between prototype PS with hydrophilic coating (PS+HC) and prototype PS without hydrophilic coating (PS-HC). We performed an analysis of the degree of luminal narrowing by microscopic examination. Using an in vivo swine bile duct dilation model made by endoscopic papillary closure and stent insertion, we evaluated biodurability of hydrophilic coating. RESULTS: In the phantom model, PS+HC showed less biofilm formation and luminal narrowing than PS-HC at 8 weeks (p<0.05). A total of 31 stents were inserted into the dilated bile duct of seven swine models, and 24 stents were successfully retrieved 8 weeks later. There was no statistical difference of stent patency between the polyethylene PS+HC and the polyurethane PS+HC. The biodurability of hydrophilic coating was sustained up to 8 weeks, when assessing the coating layer by scanning electron microscopy examination. CONCLUSIONS: Advanced hydrophilic coating technology may extend the patency of PS compared to uncoated PS.
Animals*
;
Bile Ducts*
;
Bile*
;
Biofilms
;
In Vitro Techniques
;
Microscopy, Electron, Scanning
;
Phenobarbital
;
Plastics*
;
Polyethylene
;
Polyurethanes
;
Stents*
;
Swine
8.Optimal Methods for the Management of Iatrogenic Colonoscopic Perforation.
Dae Kyu SHIN ; Sun Young SHIN ; Chi Young PARK ; Sun Mi JIN ; Yang Hyun CHO ; Won Hee KIM ; Chang Il KWON ; Kwang Hyun KO ; Ki Baik HAHM ; Pil Won PARK ; Jong Woo KIM ; Sung Pyo HONG
Clinical Endoscopy 2016;49(3):282-288
BACKGROUND/AIMS: Colonoscopic perforations have been managed with exploratory laparotomy, and have resulted in some morbidity and mortality. Recently, laparoscopic surgery is commonly performed for this purpose. The aim of this study was to compare the outcomes of several management strategies for iatrogenic colonoscopic perforations. METHODS: We retrospectively reviewed the medical records of patients who had been treated for colonoscopic perforation between January 2004 and April 2013 at CHA Bundang Medical Center in Korea. RESULTS: A total of 41 patients with colonoscopic perforation were enrolled. Twenty patients underwent conservative management with a success rate of 90%. Surgical management was performed in 23 patients including two patients who were converted to surgical management after the failure of the initial conservative management. Among 14 patients who underwent surgery at 8 hours after the perforation, there was no considerable difference in adverse outcomes between the laparotomy group and the laparoscopic surgery group. The medical costs and claim rate were 1.45 and 1.87 times greater in the exploratory laparotomy group, respectively. CONCLUSIONS: Conservative management of colonoscopic perforation could be an option for patients without overt symptoms of peritonitis or with a small defect size. If surgical management is required, laparoscopic surgery may be considered as the initial procedure even with a delayed diagnosis.
Colonoscopy
;
Delayed Diagnosis
;
Humans
;
Korea
;
Laparoscopy
;
Laparotomy
;
Medical Records
;
Methods*
;
Mortality
;
Peritonitis
;
Retrospective Studies
9.Extragastroesophageal Malignancy-Associated Secondary Achalasia: A Rare Association of Pancreatic Cancer Rendering Alarm Manifestation.
Hong Min KIM ; Ji Min CHU ; Won Hee KIM ; Sung Pyo HONG ; Ki Baik HAHM ; Kwang Hyun KO
Clinical Endoscopy 2015;48(4):328-331
Secondary achalasia or pseudoachalasia is a rare esophageal motor abnormality, which mimics primary achalasia; it is not easily distinguishable from idiopathic achalasia by manometry, radiological examination, or endoscopy. Although the majority of reported pseudoachalasia cases are associated with neoplasms at or near the esophagogastric (EG) junction, other neoplastic processes or even chronic illnesses such as rheumatoid arthritis can lead to the development of pseudoachalasia, for example, mediastinal masses, gastrointestinal (GI) tumors of the liver and biliary tract, and non-GI malignancies. Therefore, even if a patient presents with the typical findings of achalasia, we should be alert to the possibility of other GI malignancies besides EG tumors. For instance, pancreatic cancer was found in the case reported here; only four such cases have been reported in the literature. A 47-year-old man was admitted to our center with a 3-month history of dysphagia. His endoscopic and esophageal manometric findings were compatible with primary achalasia. However, unresponsiveness to diverse conventional achalasia treatments led us to suspect secondary achalasia. An active search led to a diagnosis of pancreatic mucinous cystadenocarcinoma invading the gastric fundus and EG junction. This rare case of pseudoachalasia caused by pancreatic carcinoma emphasizes the need for suspecting GI malignancies other than EG tumors in patients refractory to conventional achalasia treatment.
Arthritis, Rheumatoid
;
Biliary Tract
;
Chronic Disease
;
Cystadenocarcinoma, Mucinous
;
Deglutition Disorders
;
Diagnosis
;
Endoscopy
;
Esophageal Achalasia*
;
Gastric Fundus
;
Humans
;
Liver
;
Manometry
;
Middle Aged
;
Neoplastic Processes
;
Pancreatic Neoplasms*
10.Image Quality Analysis of Various Gastrointestinal Endoscopes: Why Image Quality Is a Prerequisite for Proper Diagnostic and Therapeutic Endoscopy.
Weon Jin KO ; Pyeong AN ; Kwang Hyun KO ; Ki Baik HAHM ; Sung Pyo HONG ; Joo Young CHO
Clinical Endoscopy 2015;48(5):374-379
Arising from human curiosity in terms of the desire to look within the human body, endoscopy has undergone significant advances in modern medicine. Direct visualization of the gastrointestinal (GI) tract by traditional endoscopy was first introduced over 50 years ago, after which fairly rapid advancement from rigid esophagogastric scopes to flexible scopes and high definition videoscopes has occurred. In an effort towards early detection of precancerous lesions in the GI tract, several high-technology imaging scopes have been developed, including narrow band imaging, autofocus imaging, magnified endoscopy, and confocal microendoscopy. However, these modern developments have resulted in fundamental imaging technology being skewed towards red-green-blue and this technology has obscured the advantages of other endoscope techniques. In this review article, we have described the importance of image quality analysis using a survey to consider the diversity of endoscope system selection in order to better achieve diagnostic and therapeutic goals. The ultimate aims can be achieved through the adoption of modern endoscopy systems that obtain high image quality.
Endoscopes
;
Endoscopes, Gastrointestinal*
;
Endoscopy*
;
Exploratory Behavior
;
Gastrointestinal Tract
;
History, Modern 1601-
;
Human Body
;
Humans
;
Narrow Band Imaging


Result Analysis
Print
Save
E-mail